Blueprint
UNITED
STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
FORM
8-K
CURRENT
REPORT
Pursuant to
Section 13 or 15(d) of
The Securities
Exchange Act of 1934
Date of Report (Date of earliest
event reported)
February 12,
2019
AEHR TEST
SYSTEMS
(Exact name of registrant as
specified in its charter)
California
|
|
000-22893
|
|
94-2424084
|
(State or other jurisdiction of
incorporation)
|
|
(Commission File
Number)
|
|
(IRS Employer Identification
No.)
|
400 KATO
TERRACE
FREMONT, CA
94539
(Address of principal executive
offices, including zip code)
510-623-9400
(Registrant’s telephone
number, including area code)
N/A
(Former name or former address, if
changed since last report)
Check the appropriate box below if
the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following
provisions (see General Instruction A.2.
below):
☐ Written communications
pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
☐ Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
☐ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
☐ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
Indicate by check mark whether the
registrant is an emerging growth company as defined in Rule 405 of
the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of
this chapter).
Emerging growth company
☐
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the
extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a)
of the Exchange Act. ☐
Item
2.05.
Costs
Associated with Exit or Disposal Activities.
On
February 12, 2019, Aehr Test Systems (the “Company”)
committed to a restructuring plan in order to streamline its
operations and better align the Company’s structure with its
objectives going forward. This restructuring plan includes
structural changes in the sales and marketing, R&D and
manufacturing operations organization
to focus the Company’s resources on the key market
opportunities in test and burn-in of devices where confidence in
reliability, security, and safety are critically
important.
The
Company currently estimates it will incur approximately $500,000 of
cash expenditures in connection with the restructuring,
substantially all of which relate to severance costs. The Company
expects to recognize these restructuring charges in the third
quarter of fiscal 2019. The restructuring plan is expected to
reduce the Company’s operating expenses by approximately
$300,000 per quarter starting in the first quarter of fiscal 2020
beginning June 1, 2019.
Item
5.02
Departure
of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.
In
connection with the restructuring described under Item 2.05 above,
Mark Allison, the Company’s Vice President of Worldwide
Sales, and Carl Buck, the Company’s Vice President of
Marketing, will cease employment with the Company effective as of
March 29, 2019. Mr. Allison and Mr. Buck are expected to receive
severance payments together totaling approximately $150,000, which
are included in the estimate of cash expenditures in connection
with the restructuring described under Item 2.05
above.
This
Current Report on Form 8-K contains forward-looking statements,
including, but not limited to, statements related to the expected
costs and annual savings associated with and the expected timing of
the restructuring plan. These forward-looking statements are based
on the Company’s current expectations and inherently involve
significant risks and uncertainties. The Company’s actual
results and the timing of events could differ materially from those
anticipated in such forward-looking statements as a result of these
risks and uncertainties. A further description of the risks and
uncertainties relating to the business of the Company is contained
in the Company’s Annual Report on Form 10-K for the year
ended May 31, 2018, filed with the Securities and Exchange
Commission (the “SEC”), and the Company’s
subsequent current and periodic reports filed with the SEC. Except
as otherwise required by law, the Company undertakes no duty or
obligation to update any forward-looking statements contained in
this Current Report on Form 8-K as a result of new information,
future events or changes in its expectations.
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the Registrant has duly caused
this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
Aehr Test
Systems
|
|
|
(Registrant)
|
|
|
|
|
|
Date: February 19,
2019
|
By:
|
/s/ KENNETH B.
SPINK
|
|
|
|
Kenneth
B. Spink |
|
|
|
Vice President of
Finance and Chief Financial Officer |
|